Bionik Laboratories (BNKL)

Data from SEC filings
Employee count
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

The Annual Meeting of Stockholders (the “Annual Meeting”) of Bionik Laboratories Corp. (the “Company”) was held on December 17, 2021. At the Annual Meeting, the stockholders of the Company voted on the following four proposals and cast their votes as described below. The proposals are described in more detail in the Company’s Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on November 17, 2021.

Proposal 1: Election of the seven nominees listed below to serve on the Board of Directors of the Company until the next Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified:

NomineeForWithhold Authority
Andre Auberton-Herve3,400,0635,091
Remi Gaston-Dreyfus3,410,49515,523
P. Gerald Malone3,400,06315,523
Joseph Martin3,400,06315,523
Charles Matine3,400,06315,523
Audrey Thevenon3,373,96741,619
Michal Prywata3,403,39812,188

Proposal 2: To approve an advisory (non-binding) resolution to approve the compensation of the Company’s named executive officers.


Proposal 3: To recommend, on an advisory (non-binding) basis, the frequency with which shareholders shall be entitled to vote on the compensation of named executive officers.

One YearTwo YearsThree YearsAbstain

Accordingly, the Company’s board of directors determined that the Company will hold a say-on-pay advisory vote every three years.

Proposal 4: To ratify MNP, LLP as the Company’s independent public accountants for the year ending March 31, 2022.